S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

LBPH Longboard Pharmaceuticals Inc

59.98

0.00 (0.00%)

Last Updated: 18:00:00

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Longboard Pharmaceuticals (NASDAQ:LBPH)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Longboard Pharmaceuticals Charts.

Longboard Pharmaceuticals (NASDAQ:LBPH)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Longboard Pharmaceuticals Charts.

Longboard Pharmaceuticals Inc News

Form 15-12G - Securities registration termination [Section 12(g)]
Thursday 12 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form POSASR - Post-effective Amendment to an automatic shelf registration statement
Tuesday 10 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form RW WD - Withdrawal of Registration Withdrawal Request
Tuesday 10 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Monday 9 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 2 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form RW - Registration Withdrawal Request
Monday 2 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Monday 2 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Monday 2 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Monday 2 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Monday 2 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 2 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
Friday 29 November 2024 (4 weeks ago) • Edgar (US Regulatory)

More Longboard Pharmaceuticals Inc News Articles

Kensington Capital Acqui...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions